Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
BMC Pulmonary Medicine|February 2, 2013
The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trialLeona Dowman, Christine F McDonald, Catherine Hill, et al.
Physiotherapy|November 25, 2015
Reliability of the hand held dynamometer in measuring muscle strength in people with interstitial lung diseaseLeona Dowman, Christine F McDonald, Catherine J Hill, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 26, 2022
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 17, 2021
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from AustraliaIngrid A Cox, Barbara de Graaff, Hasnat Ahmed, et al.
Annals of the American Thoracic Society|March 22, 2026
Consensus palliative care referral criteria for people with idiopathic pulmonary fibrosis: An international Delphi studyAmy Pascoe, Natasha Smallwood, Jennifer Philip, et al.
Rheumatology (Oxford, England)|October 16, 2012
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Nicole Goh, Tamera Corte, et al.
Clinical and Experimental Rheumatology|August 6, 2015
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseOwen A Moore, Susanna M Proudman, Nicole Goh, et al.
Respirology (Carlton, Vic.)|August 16, 2014
Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative projectYuben Moodley, Nicole Goh, Ian Glaspole, et al.
BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Pageof 5